Show simple item record

Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them (Protocol)

dc.contributor.authorBurton, Martin
dc.contributor.authorClarkson, Janet E.
dc.contributor.authorGoulao, Beatriz
dc.contributor.authorGlenny, Anne-Marie
dc.contributor.authorMcBain, Andrew J.
dc.contributor.authorSchilder, Anne G.M.
dc.contributor.authorWebster, Katie E.
dc.contributor.authorWorthington, Helen V
dc.date.accessioned2021-05-19T23:08:17Z
dc.date.available2021-05-19T23:08:17Z
dc.date.issued2020-05-20
dc.identifier163495008
dc.identifier59d26d11-39ca-4e79-a34b-133d88cc9b06
dc.identifier85085077972
dc.identifier.citationBurton , M , Clarkson , J E , Goulao , B , Glenny , A-M , McBain , A J , Schilder , A G M , Webster , K E & Worthington , H V 2020 , ' Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them (Protocol) ' , Cochrane Database of Systematic Reviews , vol. 2020 , no. 5 , CD013627 . https://doi.org/10.1002/14651858.CD013627en
dc.identifier.issn1469-493X
dc.identifier.urihttps://hdl.handle.net/2164/16506
dc.descriptionSources of support Internal sources No sources of support supplied External sources National Institute for Health Research, UK Infrastructure funding for Cochrane ENT and Cochrane Oral Health Acknowledgements We would like to thank the peer reviewers, Professor Jeremy Bagg, Dr Karolin Hijazi, Professor Carl Philpott and Professor Claire Hopkins, for their insightful comments which helped us to improve these protocols. Thanks also to Professor Peter Tugwell, Senior Editor Cochrane MOSS Network, for acting as sign‐off editor for these projects. We are also grateful to Doug Salzwedel from the Cochrane Hypertension Group for providing search peer review comments for the draft search strategy. This project was supported by the National Institute for Health Research, via Cochrane Infrastructure, Cochrane Programme Grant or Cochrane Incentive funding to Cochrane ENT and Cochrane Oral Health. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health.en
dc.format.extent11
dc.format.extent138821
dc.language.isoeng
dc.relation.ispartofCochrane Database of Systematic Reviewsen
dc.subjectRK Dentistryen
dc.subjectPharmacology (medical)en
dc.subjectNational Institute for Health Research (NIHR)en
dc.subject.lccRKen
dc.titleAntimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID-19 infection to improve patient outcomes and to protect healthcare workers treating them (Protocol)en
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Health Services Research Uniten
dc.description.statusPeer revieweden
dc.identifier.doi10.1002/14651858.CD013627
dc.date.embargoedUntil2021-05-20
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85085077972&partnerID=8YFLogxKen


Files in this item

Thumbnail
Name:
Burton_et_al_CDSR_Antimicrobia ...
Size:
135.5Kb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record